aip-303
mAbexperimental
Clinical trial activity
1 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 30, 2020 (NCT04469127)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
ERBB2 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04469127 | Phase 1/Phase 2 (Phase 2) | Aug 30, 2020 | Advanced Imaging Projects, Advanced Imaging Projects, LLC, All India Institute of Medical Sciences, Department of Veteran Affairs, PositronPharma, Postgraduate Institute of Medical Education and Research, Università degli studi di Trieste, University of Lausanne, University of the Witwatersrand |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Advanced Imaging Projects | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Advanced Imaging Projects, LLC | For profit | 1 | 1 | 1 | 2020 |
| All India Institute of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2020 |
| PositronPharma | For profit | 1 | 0 | 1 | 2020 |
| Postgraduate Institute of Medical Education and Research | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Università degli studi di Trieste | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Lausanne | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of the Witwatersrand | Academic/Hospital | 1 | 0 | 1 | 2020 |
9 organizations
Page 1 / 1